COVID
Clinical trials for COVID explained in plain language.
Never miss a new study
Get alerted when new COVID trials appear
Sign up with your email to follow new studies for COVID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New test aims to spot coronaviruses faster and more accurately
Diagnosis Recruiting nowThis study is testing a new diagnostic panel called the BioFire ECoV Panel, designed to detect coronaviruses from leftover nose swab samples. Researchers will enroll 1,500 people and compare the panel's results to standard tests to see how accurate it is. The test is not being us…
Matched conditions: COVID
Sponsor: BioFire Defense LLC • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
New At-Home COVID test put to the test in 1,000-Person study
Diagnosis Recruiting nowThis study checks if a new COVID-19 test (Metrix COVID Test) works well when used at home or in clinics. About 1,000 people with COVID symptoms will take the test, and results will be compared to a standard FDA-cleared test. The goal is to see if the new test accurately detects t…
Matched conditions: COVID
Phase: NA • Sponsor: Aptitude Medical Systems • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
COVID-19's skin secrets: could chilblains hold clues to the virus?
Knowledge-focused Recruiting nowThis study looks at skin problems that appear during a COVID-19 infection, with a special focus on chilblains (painful red or purple bumps on fingers or toes). Researchers want to understand why these skin changes happen—whether from the virus itself, tiny blood clots, or inflamm…
Matched conditions: COVID
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
AI aims to revolutionize cancer trial enrollment for 50,000 patients
Knowledge-focused Recruiting nowThis study is testing whether an artificial intelligence (AI) tool can help match cancer patients with the right clinical trials. Researchers will enroll up to 50,000 people with various cancers to see if the AI improves trial enrollment rates and patient outcomes. The goal is to…
Matched conditions: COVID
Sponsor: Massive Bio, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC